•  
  •  
  •  
  •  

2025-08-08 17:55:27

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • BSE Ltd reports consolidated PAT of Rs. 539.41 crores in Q1 FY2026
  • Best Agrolife Ltd posts consolidated profit of Rs. 19.92 crores in Q1 FY2025-26
  • NBCC India Ltd Q1FY26 consolidated PAT at Rs. 132.12 crores
  • Godrej Consumer Products Ltd reports consolidated PAT of Rs. 452.45 crores in Q1 FY2026
  • National Aluminium Company Ltd consolidated Q1 FY2026 net profit at Rs. 1049.48 crores

Keywords Selected:  FinalApproval

Stock Report

  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg
  • Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg and 400 mg
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials
  • Zydus receives final approval from USFDA for Isotretinoin Capsules USP, 10 mg 20 mg, 25 mg, 30 mg, 35 mg and 40 mg
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Amlodipine and Atorvastatin Tablets USP
  • Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200 mg
  • Alembic Pharmaceuticals receives USFDA Final Approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Haloperidol Decanoate Injection
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg
  • Eugia Pharma receives USFDA Approval for Dasatinib Tablets
  • Caplin Steriles Ltd gets USFDA approval for Phytonadione Injectable Emulsion
  • Alembic Pharmaceuticals receives USFDA Final Approval for Carbamazepine Tablets USP, 200 mg
  • Royal Sense Limited receives final approval from USFDA for products
  • Bliss GVS Pharma Ltd's partner gets final approval from USFDA for Mesalamine Suppositories 1000 mg
  • Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
  • Cipla Limited receives USFDA final approval for ANDA Protein-bound Paclitaxel
  • Concord Biotech Limited receives final approval from USFDA for Teriflunomide Tablets
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial - Single-Dose Vial
  • Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg
  • Zydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg
  • Lupin Launches Rivaroxaban Tablets USP, 2.5mg in the United States
  • Zydus receives final approval from USFDA for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg
  • Caplin Steriles gets USFDA approval for Levetiracetam in Sodium Chloride Injection, Infusion Bags
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg

Latest Post

  • BSE Ltd reports consolidated PAT of Rs. 539.41 crores in Q1 FY2026
  • Best Agrolife Ltd posts consolidated profit of Rs. 19.92 crores in Q1 FY2025-26
  • NBCC India Ltd Q1FY26 consolidated PAT at Rs. 132.12 crores
  • Godrej Consumer Products Ltd reports consolidated PAT of Rs. 452.45 crores in Q1 FY2026
  • National Aluminium Company Ltd consolidated Q1 FY2026 net profit at Rs. 1049.48 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024